Phase IV
Showing 1 - 25 of >10,000
Epidemic Meningitis Trial (MCV4)
Not yet recruiting
- Epidemic Meningitis
- MCV4
- (no location specified)
Jul 5, 2023
Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small
Recruiting
- CLL/SLL
-
Jinan, Shandong, ChinaDepartment of Hematology, Shandong Provincial Hospital Affiliate
Jun 16, 2023
Latent Tuberculosis Infection Trial (Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected)
Not yet recruiting
- Latent Tuberculosis Infection
- Recombinant Mycobacterium tuberculosis fusion protein for injection
- TB-PPD was injected
- (no location specified)
Feb 16, 2023
Latent Tuberculosis Infection Trial (Mycobacterium Vaccae for Injection)
Not yet recruiting
- Latent Tuberculosis Infection
- Mycobacterium Vaccae for Injection
- (no location specified)
Dec 23, 2022
Edema Due to Heart Failure or Cirrhosis Trial in Hyderabad, (Spironolactone Oral Suspension)
Completed
- Edema Due to Heart Failure or Cirrhosis
- Spironolactone Oral Suspension
-
Hyderabad,, Telangana, IndiaClinSync Clinical Research Pvt. Ltd.
Aug 28, 2023
Clinical Study of Stage IV Psoriasis in Children With Geleli
Not yet recruiting
- Plaque Psoriasis
- (no location specified)
Mar 26, 2023
CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)
Not yet recruiting
- CYP3A4*22
- Palbociclib 125Mg Tab
- +2 more
- (no location specified)
Jan 10, 2023
From Phase III to IV Cardiac Rehabilitation
Not yet recruiting
- Cardiovascular Diseases
-
Caerleon, Gwent, United Kingdom
- +2 more
Mar 13, 2023
Evaluating the SUBLOCADE Treatment Exit Strategy
Not yet recruiting
- Opioid Use Disorder
- (no location specified)
May 17, 2023
Polyneuropathy, Diabetic Trial in Egypt (Alpha-Lipoic Acid (ALA), Placebo)
Recruiting
- Polyneuropathy, Diabetic
- Alpha-Lipoic Acid (ALA)
- Placebo
-
Alexandria, Bab Sharqi, Egypt
- +4 more
Apr 3, 2023
SUBLOCADE Long-term Outcomes
Not yet recruiting
- Opioid Use Disorder
- (no location specified)
May 5, 2023
Carcinoma, Ovarian Epithelial Trial in San Fermo Della Battaglia, Padova (Olaparib, Bevacizumab)
Recruiting
- Carcinoma, Ovarian Epithelial
-
San Fermo Della Battaglia, Como, Italy
- +1 more
Nov 2, 2023
Skin Laxity; Facial, Dry Skin; Facial Trial (HydraFacial Syndeo System, ReGen-GF)
Not yet recruiting
- Skin Laxity; Facial
- Dry Skin; Facial
- HydraFacial Syndeo System
- ReGen-GF
- (no location specified)
Jun 27, 2023
Cancer Of Pancreas Trial (Analyze of GemCore status)
Not yet recruiting
- Cancer Of Pancreas
- Analyze of GemCore status
- (no location specified)
Sep 19, 2023
Shoulder Arthroscopy, Pain Trial in New York (IV Saline, IV Dexamethasone 4mg, IV Dexamethasone 6mg)
Completed
- Shoulder Arthroscopy
- Pain
- IV Saline
- +3 more
-
New York, New YorkHospital for Special Surgery
May 11, 2022
Osteoporosis Trial in Seoul (Masibone S, Fosamax)
Recruiting
- Osteoporosis
- Masibone S
- Fosamax
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 24, 2022
Post Operative Pain, Acute, Bariatric Surgery Candidate, Postoperative Pain Trial in Holyoke (ZYNRELEF 200Mg-6Mg
Recruiting
- Post Operative Pain, Acute
- +2 more
- ZYNRELEF 200Mg-6Mg Extended-Release Solution
-
Holyoke, MassachusettsHolyoke Medical Center
May 16, 2023
Photorefractive Keratectomy, Corneal De-epithelialization Trial (Sodium Hyaluronate Ophthalmic 0.4%, Trehalose 3% / Sodium
Not yet recruiting
- Photorefractive Keratectomy
- Corneal De-epithelialization
- Sodium Hyaluronate Ophthalmic 0.4%
- Trehalose 3% / Sodium Hyaluronate Ophthalmic 0.15%
- (no location specified)
Mar 23, 2022
Breast Cancer Trial in France, Germany (Intraoperative radiotherapy (IORT))
Active, not recruiting
- Breast Cancer
- Intraoperative radiotherapy (IORT)
-
Montpellier, France
- +3 more
May 30, 2022
Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)
Not yet recruiting
- Obesity
- Naltrexone-Bupropion (NB) Combination
- Placebo
- (no location specified)
Oct 18, 2023
